Troponin- I Elevation Predicts Outcome After Thrombolysis in Stroke Patients

NCT03925298 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 81

Last updated 2019-04-24

No results posted yet for this study

Summary

Elevated level of serum troponin (T-I) has been regarded as a prognostic biomarker of poor outcome in acute ischemic stroke. However, its role in outcome in thrombolysed ischemic stroke patients remains uncertain. The aim of this study was to evaluate the role of T-I as a predictive biomarker of short-term outcome in thrombolysed ischemic stroke participants.

Conditions

  • Cerebrovascular Accident

Sponsors & Collaborators

  • Zagazig University

    lead OTHER_GOV

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2019-01-31
Completion
2019-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03925298 on ClinicalTrials.gov